Introduction
Genetic manipulation of neurons by gene transfer into the central nervous system (CNS) has been limited for a long time due to the lack of suitable vector systems. Such vectors (i) should be safe and capable of transducing non-cycling cells like neurons, (ii) should not express any vector specific and potentially immunogenic proteins, and (iii) should allow for large-scale production, concentration, and purification in order to inject vector preparations with minimal damage to the neighboring tissue. For efficient gene transfer into CNS neurons, the recent development of lentiviral, HIV-1-derived vectors represents a major progress. Unlike conventional oncoretroviral vectors, the karyophilic properties of pseudotyped lentiviruses allow efficient transduction of noncycling cells such as neurons, glial cells, hepatocytes as well as hematopoietic stem cells. [1] [2] [3] [4] [5] [6] [7] In addition, lentiviral as well as oncoretroviral vectors allow for stable integration of the transgene into the host cell genome and do not express any viral proteins in transduced cells. 8 However, the lack of space for deposits of large volumes within the CNS tissue and difficulties to approach the target area appropriately have required special tools and methods in neurosurgery. Accordingly, advances in stereotactic injection methods now allow safe injection of small volumes, for example, of lentiviral preparations, even under local anesthesia.
On the vector side, pseudotyping of lentiviral vectors with vesicular stomatitis virus glycoprotein (VSV-G) not only extends the range of cells to be transduced but also stabilizes recombinant lentiviral particles allowing the concentration of viral supernatants, for example, by ultracentrifugation. [9] [10] [11] [12] However, ultracentrifugation allows only limited volumes of viral vector containing supernatant to be concentrated. In addition, deposit of lentiviral preparations into the CNS requires the clearance of viral supernatants from potentially toxic or immunogenic contaminations with aggregates, cellular debris, and /or components of the tissue culture media used to transiently produce the viral particles. These factors are detrimental for transduction in vitro and can cause tissue injury and acute short-and long-term immune responses in vivo. 13 We therefore applied anion exchange chromatography, which is usually used to deplete plasma products from viral contaminants, in order to enrich and purify lentiviral supernatants. Concentration and yield of lentiviral particles were quantified by real-time PCR.
14 Viral supernatants purified and concentrated by either anion exchange chromatography column or ultracentrifugation were tested for their transduction efficiency in neuronal and glial cells by direct stereotactic injection into the adult rat brain in vivo. With almost unlimited starting volumes of viral supernatants, anion exchange chromatography enables viral concentration with similar efficacy and yield as conventional ultracentrifugation. Column concentrated viral preparations can transduce adult CNS neurons with high efficiency after stereotactic direct injections without any signs of toxicity or inflammation.
Results

Preparation and concentration of lentiviral vectors
Lentiviral vectors were generated by transient transfection of 293T cells according to standard procedures (see the Material and Methods section for details). As anion exchange columns, containing a weak anion exchanger (Fractoflow s DEA 80-6 column, MerckKGaA, Germany), have been widely used to remove viral contaminants from blood products, we chose this column for the concentration and purification of lentiviral particles. The viral supernatants (200-250 ml) were applied to a Fractoflow DEA column at a flow rate of 4 ml/min using gravitational force. The column was washed once with PBS (100 ml) and the VSV-G pseudotyped virus particles bound to the column were eluted with PBS containing 2-3 M NaCl, desalted and further concentrated using a 100 000 MW cut-off Vivaspin filter (Vivascience Ltd, UK). Finally, the viral suspension was equilibrated with X-VIVO10.
To determine vector recovery, we used the minus strong-stop cDNA (U5/R region) present within lentivirus capsids as a template for quantitative real-time PCR. In addition, conventional biological end-point titrations were performed. 15 For real-time PCR, serial dilutions (10-fold) of the lentiviral transgene plasmid pRRL-CGW-SIN were used to establish a standard curve (Figure 1, inset ). An inverse correlation between copy number and normalized fluorescence intensity was observed over 4 logs (2 Â 10 5 to 2 Â 10 2 molecules per PCR reaction). The number of viral particles within viral vector stocks was determined by real-time PCR before ( Figure 1 , curve I) and after purification by anion exchange chromatography (Figure 1 , curve II). Since samples eluted from the column contained high salt concentrations, vector preparations were desalted and further concentrated by Vivaspin filtration and quantitated again by real-time PCR (Figure 1, , n ¼ 10) particles/ml. The concentration of lentiviral vector preparations based on volume ranged between 78-and 143-fold (mean ¼ 104.5-fold, n ¼ 10) while vector recovery after anion exchange chromatography as determined by PCR ranged between 22.4% and 68.1% (mean ¼ 44.8%, n ¼ 10) (Figure 2) .
In parallel to the quantitative real-time PCR, the biological titers of the vector preparations were determined by end-point dilution. According to this, the number of infectious particles ranged between 5.0 Â 10 SDS-PAGE analysis of the lentiviral vector supernatants showed less overall protein content in preparations purified by anion exchange chromatography than those concentrated by ultra-centrifugation ( Figure 3a) . A Western blot analysis for VSV-G detected large amounts of protein in the fraction concentrated by ultracentrifugation with a high molecular weight complex of about 160-180 kDa corresponding probably to aggregates of VSV-G (Figure 3b ). In contrast, no high molecular weight complexes were detected in lentiviral vector preparations purified by anion exchange chromatography. Moreover, an estimation of the infectivity (TU/p24) of virus preparations concentrated either by chromatography or ultracentrifugation revealed higher infectivity for column purified viruses (1.57 Â 10 5 versus 7.9 Â 10 4 , respectively). These studies showed that virus particles concentrated by anion exchange chromatography contain less contaminants than those obtained after ultracentrifugation and are therefore better suitable for in vivo applications (see below).
Transduction of central nervous system cells with lentiviral vectors concentrated by anion exchange chromatography
Lentiviral vector preparations were used to transduce neuronal and glial cells in vivo. All adult rat brains injected with 3 ml of concentrated lentiviral vector preparations encoding for green fluorescent protein showed large areas expressing the transgene (injection sites n ¼ 10, Figure 4a ). After 8 weeks, coronal sections of perfused rat brains were analyzed for eGFP-expressing cells in the striatum (Figure 4b ). Immunofluorescent staining with a rabbit polyclonal antibody against eGFP 6 to 2 Â 10 1 copies) of the lentiviral-transgene plasmid pRRL-CGW-SIN in 100 mg/ml herring sperm DNA (100 mg/ml) were prepared in triplicate and subjected to real-time PCR as described in the text (inset in the figure) . Determination of the number of particles by real-time PCR after virus concentration through Fractoflow columns. Cell culture supernatant (curve I) was concentrated 10-fold on Fractoflow columns (curve II), desalted and further concentrated (10-fold) by ultrafiltration (curve III). The various viral supernatants were diluted 100-fold in herring sperm DNA (100 mg/ml) and subjected to real-time PCR. DRn denotes the normalized reporter signal (Rn) minus baseline signal detected during the first 15 PCR cycles. No signal was obtained with herring sperm DNA without template. 
Discussion
Since in vivo gene transfer into the CNS only allows for injection of small volumes, highly concentrated and purified viral preparations are required for non-toxic and efficient gene transfer. Anion exchange chromatography has been previously used to purify inactivated HIV-1 particles for immune-based therapy purposes. 16 These particles were found to be of high purity (4 95%) as estimated by analytical gel filtration and thin section electron microscopy. 17 In our study, we demonstrate that anion exchange chromatography can also be used for the concentration of infectious, VSV-G pseudotyped lentiviral vector particles without major loss in infectivity. This procedure results in vector preparations of high quality and purity, which can be concentrated to very small volumes. In addition, anion exchange chromatography allows for columns to be loaded with large volumes of vector supernatants, limited only by the protein binding capacity of the columns (approximately 40 mg/ml). Columns are available in different sizes and can be applied in parallel settings, allowing for large-scale Figure 2 Results of 10 vector preparations before and after purification on anion exchange chromatography. PCR and end-point dilution were used to titer the viral supernatants. Fold concentration was determined by the reduction in volume whereas vector particle numbers were determined by PCR as described in the Material and methods section. 
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purification of vector preparations. The columns are reusable and can be easily connected to peristaltic pumps, thus allowing for the loading, washing, and elution of the viral vectors as a semi-automatic process. Using this system, we succeeded in concentrating up to 1 l of vector supernatant in 1 h, as required in future application on larger biological systems. Anion exchange chromatography has been established as a fast routine procedure for the production of large quantities of lentiviral vectors and has been utilized in over 50 procedures in our lab. The recovery of lentiviral particles as determined by real-time PCR after anion exchange chromatography, desalting, and vivaspin filtration ranged between 22% and 68% with a concentration fold between 78 and 143 (average 104.5-fold). The number of infectious particles was found to be 100-fold less than the total amount of particles. This two log difference is not unusual since similar values have been observed for Mo-MuLV-based retroviral vectors. 18 The PCR methodology detects nucleic acids within the particles irrespective of virus infectivity. In contrast, titer determination by end-point dilution requires fully functional virus particles. It is well known that virus-producing cells generate a large number of defective particles, for example core particles lacking the envelope glycoproteins. Moreover, virusproducing cells shed empty envelopes into the cell culture media, which may interfere with transduction of target cells by blocking the viral receptors. These factors and others (eg binding of vector particles to components of the cell culture media and plastic surfaces) may reduce the number of infectious virions, thereby reducing transduction efficiency. 19 After anion exchange chromatography, we were able to demonstrate efficient long-term transgene expression in the adult CNS by injecting minimal (3 ml) volume of highly concentrated lentiviral preparations into the striatum without any signs of acute tissue damage or immune response. Immunohistochemistry of the anion exchange chromatography purified lentiviral vector injected brains revealed on signs of inflammation or immune response in contrast to animals injected with vectors prepared by ultracentrifugation. The transgene was stably expressed mainly in neurons and oligodendrocytes. This may be due to receptor specificity or difference in promoter activity and is in accordance with previously published results. 20, 21 In our study, the use of column-purified lentiviral vectors did not cause any acute infiltration of immune cells into the injection sites. This is a clear sign of the purity of the vector preparation and correlates with the well-known fact that lentiviral vectors do not evoke an immune response by viral protein expression. For in vivo approaches, the removal of any immunogenic potential of viral vectors is strongly required and is one of the crucial steps for entering pre-clinical trials avoiding acute immune response and tissue damage due to foreign protein contained in the vector preparation. Not only long-term viral protein expression as seen in the adeno-viral vector applications but also short-term immune response based on impurity of vector preparations can inhibit transgene expression and damage transgene expressing cells. 22, 23 Our main goal was to prepare highly purified lentiviral vectors in small volumes for direct in vivo stereotactic injections into the brain. We demonstrate that column-purified lentiviral vectors provide a safe and efficient method for gene delivery, allowing for transgene expression without damage to the tissue or to single cells.
Our current efforts are focused on the optimization of gene transfer protocols by lentiviral vectors into the CNS with highly efficient and purified vector preparations. This represents a pre-requirement for any potential clinical application of gene transfer into the CNS. The described concentration procedure generates very pure and therefore less toxic lentiviral vector preparations, 
thus improving their quality. This method allows for virus purification and concentration in a reliable, reproducible, and easy to handle fashion. In agreement with our observations, purification of adeno-associated viral vectors by column chromatography also leads to a substantial improvement in virus quality and purity. 24 This suggests that column chromatography may turn out to be the procedure of choice, especially when very small volumes of highly pure viral preparations and efficient and scaleable downstream processing are required, as is the case in clinical applications.
Material and methods
Production and concentration of viral stocks
Lentiviral vectors were produced on human kidney 293T producer cells after transient transfection with the three constructs described below. Cells (2 Â 10 7 ) were plated on poly-L-lysine-coated T175 flasks in Iscove's modified Dulbecco's culture medium with 10% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 mg/ml) (all from Life Technologies, Karlsruhe, Germany). The lentiviral vector used in these studies (pRRL-CGW-SIN) was derived from the pRRL.SIN-18 series of constructs described Zufferey et al 25 and contains the eGFP (enhanced green fluorescent protein) gene under the transcriptional control of a CMV promoter, and the woodchuck hepatitis virus post-transcriptional regulatory element. 26 Transfection cocktails contained 60 mg of the lentiviral transgene plasmid pRRL-CGW-SIN, 45 mg of the packaging plasmid pCMVD8.9.3, 8 and 30 mg of the VSV-Gexpressing plasmid pMDG. Cell culture medium was replaced 8 h after transfection with medium containing 10 mM sodium butyrate (Upstate Biotechnology, NY, USA). Supernatants were harvested in DMEM every 24 h for 3 days, pooled, cleared by low-speed centrifuga- Vector particles were concentrated either by anion exchange chromatography on a Fractoflow s 80-6 (MerckKGaA, Darmstadt, Germany) column (diameter 0.6 cm, length 8 cm) or ultracentrifugation. The column consists of six hollow fibers, 0.5 mm outer diameter and 0.3 mm inner diameter, with a maximum pore size of 0.6 mm, about 70 mg binding capacity for standard proteins. Columns were washed with phosphate buffered saline (PBS), and VSV-G pseudotyped vectors bound to the column were eluted with 2 M NaCl in PBS using a flow rate of 4 ml/min. Volumes processed ranged between 250 and 500 ml. Preparations were desalted and further concentrated using a 100 000 MW cut-off Vivaspin filter (Vivascience Ltd, Lincoln, UK). Finally, the viral vector concentrate was equilibrated in X-VIVO10. Viral vector preparations concentrated by ultracentrifugation were centrifuged twice at 50 000 g for 90 min and resuspended in X-VIVO. Biological titrations of concentrated supernatants were performed in triplicate by serial dilutions of the vector stocks in the presence of polybrene (8 mg/ml) on 1 Â 10 5 293T cells in 24-well plates. After 4-6 h incubation, the culture medium was changed and 72 h later the number of eGFP positive colonies was counted under a fluorescence microscope.
Quantification of lentiviral vector particles based on real-time PCR
The procedure described by Towers et al was adapted to lentiviral vectors and used for the quantification of vector particles. 18 The primer pair and probe used for the real-time PCR were: U5-forward:
0 (all Perkin Elmer/ABI, Weiterstadt, Germany). Viral particle numbers were calculated from a standard curve constructed from serial dilutions of the lentiviral transgene plasmid pRRL-CGW-SIN in herring sperm DNA (100 mg/ml). Real-time PCR was performed using an ABI PRISM 7700 Sequence Detector and the ABI PRISM 7700 Sequence Detector Software 1.6.4 (Perkin Elmer/ABI, Weiterstadt, Germany).
Vector particle containing supernatants were diluted 1:10-100 and concentrated viral vector preparations 1:100-10 000 and amplified by PCR in triplicate. Amplification mixes (50 ml) contained various dilutions of viral vector supernatant (10 ml), 1 Â TaqMant buffer, 200 mM dNTPs, 5.5 mM MgCl 2 , 0.9 mM of each primer, 200 nM TaqMant probe and 0.5 ml AmpliTaq Gold (0.025 U/ml). Reaction conditions were 2 min at 501C, an initial denaturation at 951C for 10 min followed by 40 cycles of a two-step PCR (951C, 15 s; 601C, 60 s).
Transduction of neuronal and glial cells in vivo
For in vivo transduction, adult female Fischer 344 rats were anesthetized (44 mg/kg ketamine, 0.75 mg/kg acepromazine, 4 mg/kg xylazine, in 0.9% NaCl i.m.) and 3 ml of the concentrated lentiviral vector preparation was injected into the striatum (AP +0.2, ML 7 3.5, DVÀ4.5) bilaterally using a 5 ml Hamilton syringe. 3, 4, 27 After 8 weeks, the animals were killed and perfused intracardially with saline, 4% paraformaldehyde, and 0.2% glutaraldehyde. The brains were removed, postfixed, and saturated in 30% sucrose. Brains were frozen sectioned on a sliding microtome into 50 mm slices. 
Purification of lentiviral vectors M Scherr et al
Primary antibodies (Ab) used for immunohistochemistry were incubated overnight at 41C in the following dilution: rabbit-AB against GFP (Molecular Probes, 1:4000), mouse-Ab against NeuN detecting terminally differentiated neurons (Chemicon, 1:200), guinea pig-Ab against GFAP detecting astrocytes (Advanced Immunochemicals, 1:250), mouse-Ab against Rip detecting oligodendrocytes (Chemicon, 1:20 000), mouse-Ab against ED1 detecting macrophages/microglia (Secrotec, Wiesbaden, Germany, 1:500); mouse-Ab against OX8 detecting CD8, cytotoxic/suppressor T cells (Serotec, Wiesbaden, Germany, 1:500); mouse-Ab against his14 detecting CD45 positive cells (Saxon Biochemical Hannover, Germany, 1:60); mouse-Ab against OX35 detecting CD4 positive cells (Serotec, Wiesbaden, Germany, 1:500).
Corresponding fluorescent-coupled secondary antibodies (Cy3, TR, Cy5, FITC, Jackson, USA, 1:250) were used and nuclear staining was achieved by diamidino-2-phenylindole (Molecular Probes, USA). The sections were analyzed by confocal scanning laser microscopy (Leica, Germany). The signals were collected, digitally color enhanced and superimposed with Photoshop 5.0 (Adobe Photoshop).
